INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 24 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,902 | +12.3% | 10,000 | +11.1% | 0.00% | – |
| Q4 2022 | $8,820 | -2.0% | 9,000 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | 0.0% | 9,000 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | +12.5% | 9,000 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | 0.0% | 9,000 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | +100.0% | 9,000 | +80.0% | 0.00% | – |
| Q3 2021 | $4,000 | +33.3% | 5,000 | +66.7% | 0.00% | – |
| Q2 2021 | $3,000 | +50.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -60.0% | 3,000 | -50.0% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 6,000 | +20.0% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -20.0% | 5,000 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | -77.3% | 5,000 | -80.0% | 0.00% | – |
| Q3 2019 | $22,000 | +10.0% | 25,000 | +13.6% | 0.00% | – |
| Q2 2019 | $20,000 | -84.7% | 22,000 | -83.3% | 0.00% | – |
| Q1 2019 | $131,000 | +907.7% | 132,000 | +842.9% | 0.00% | – |
| Q4 2018 | $13,000 | -97.9% | 14,000 | -97.7% | 0.00% | -100.0% |
| Q3 2018 | $609,000 | -88.4% | 603,000 | -90.0% | 0.00% | -80.0% |
| Q2 2018 | $5,271,000 | +67.3% | 6,020,000 | +53.4% | 0.01% | +66.7% |
| Q1 2018 | $3,150,000 | +22.5% | 3,925,000 | +21.3% | 0.00% | +50.0% |
| Q4 2017 | $2,572,000 | +40.5% | 3,235,000 | +36.6% | 0.00% | +100.0% |
| Q3 2017 | $1,830,000 | +44.1% | 2,369,000 | +73.8% | 0.00% | 0.0% |
| Q1 2017 | $1,270,000 | +35.7% | 1,363,000 | +29.8% | 0.00% | 0.0% |
| Q4 2016 | $936,000 | +735.7% | 1,050,000 | +950.0% | 0.00% | – |
| Q3 2016 | $112,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|